Engraftment, graft-vs-host disease (GVHD), and survival after CD8+T cell depleted allogeneic peripheral blood stem cell transplantation (PBSCT).

被引：0
|
作者：
Soiffer, RJ [1 ]
Alyea, EP [1 ]
Kim, H [1 ]
Parikh, B [1 ]
Ho, V [1 ]
Hochberg, E [1 ]
Levin, J [1 ]
Fisher, DC [1 ]
Lee, SJ [1 ]
Antin, JH [1 ]
机构：
[1] Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1619
引用
收藏
页码：418A / 418A
页数：1
相关论文
共 50 条
  • [31] The lung function score and its components as predictors of overall survival and chronic graft-vs-host disease after allogeneic stem cell transplantation
    Ditz, Diana
    Rabanus, Robert
    Schulz, Christian
    Wolff, Daniel
    Holler, Barbara
    Holler, Ernst
    Hildebrandt, Gerhard Carl
    CROATIAN MEDICAL JOURNAL, 2016, 57 (01) : 16 - 28
  • [32] Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease
    V T Ho
    H T Kim
    S Li
    E P Hochberg
    C Cutler
    S J Lee
    D C Fisher
    E Milford
    G Kao
    H Daley
    J Levin
    A Ng
    P Mauch
    E P Alyea
    J H Antin
    R J Soiffer
    Bone Marrow Transplantation, 2004, 34 : 987 - 994
  • [33] Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease
    Ho, VT
    Kim, HT
    Li, S
    Hochberg, EP
    Cutler, C
    Lee, SJ
    Fisher, DC
    Milford, E
    Kao, G
    Daley, H
    Levin, J
    Ng, A
    Mauch, P
    Alyea, EP
    Antin, JH
    Soiffer, RJ
    BONE MARROW TRANSPLANTATION, 2004, 34 (11) : 987 - 994
  • [34] LONGITUDINAL MONITORING OF IMMUNE RECONSTITUTION AFTER ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION (PBSCT): IMPACT OF T-CELL DEPLETION OF THE GRAFT
    Servais, S.
    Hannon, M.
    Daulne, C.
    Gothot, A.
    Yves, B.
    Baron, F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S274 - S275
  • [35] Allogeneic hematopoietic stem cell transplantation (HSCT) without prophylaxis of Graft-vs-Host disease (GVHD) - Adoptive cellular immunotherapy of leukemia.
    Duerst, RE
    Zwetsch, L
    Senf, E
    Abboud, CN
    Liesveld, JL
    BLOOD, 1998, 92 (10) : 342B - 342B
  • [36] Rapid hematological recovery without graft-vs-host disease (GVHD) following G-CSF-mobilized T cell depleted allogeneic peripheral blood precursor cell (PBPC) transplants for hematological malignancy.
    Barrett, AJ
    Read, EJ
    Vigue, F
    Mavroudis, D
    Carter, C
    Dunbar, C
    Phang, S
    Benyunes, M
    Jacobs, C
    Young, NS
    BLOOD, 1997, 90 (10) : 452 - 452
  • [37] Elucidation of molecular markers for the diagnosis of chronic graft-vs-host disease developing after allogeneic hematopoietic stem cell transplantation
    Park, S.
    Im, S. N.
    Kim, I.
    Jeon, E.
    Won, J-H
    BONE MARROW TRANSPLANTATION, 2017, 52 : S485 - S486
  • [38] Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
    Wu, Hengwei
    Shi, Jimin
    Luo, Yi
    Tan, Yamin
    Zhang, Mingming
    Lai, Xiaoyu
    Yu, Jian
    Liu, Lizhen
    Fu, Huarui
    Huang, He
    Zhao, Yanmin
    JAMA NETWORK OPEN, 2021, 4 (01)
  • [39] The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation
    Hidaka, Daisuke
    Hayase, Eiko
    Shiratori, Souichi
    Hasegawa, Yuta
    Ishio, Takashi
    Tateno, Takahiro
    Okada, Kohei
    Goto, Hideki
    Sugita, Junichi
    Onozawa, Masahiro
    Nakagawa, Masao
    Kahata, Kaoru
    Endo, Tomoyuki
    Hashimoto, Daigo
    Teshima, Takanori
    CLINICAL TRANSPLANTATION, 2018, 32 (09)
  • [40] Is there an increased risk of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation?
    Koc, H
    Gurman, G
    Arslan, O
    Ozcan, M
    Akan, H
    Ilhan, O
    Konuk, N
    Beksac, M
    Uysal, A
    BLOOD, 1996, 88 (06) : 2362 - 2364
12345